Ameritas Investment Partners’s Nautilus Biotechnolgy NAUT Stock Holding History

Ameritas Investment Partners’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.44K	Buy	+4,513	New	+$11.9K	﹤0.01%	3040
2025 Q2	–	Sell	-3,575	Closed	-$3.08K	–	3289
2025 Q1	$3.08K	Hold	3,575	–	–	﹤0.01%	3042
2024 Q4	$6.01K	Hold	3,575	–	–	﹤0.01%	3007
2024 Q3	$10.2K	Hold	3,575	–	–	﹤0.01%	2912
2024 Q2	$8.37K	Hold	3,575	–	–	﹤0.01%	2975
2024 Q1	$10.5K	Hold	3,575	–	–	﹤0.01%	2802
2023 Q4	$10.7K	Hold	3,575	–	–	﹤0.01%	2827
2023 Q3	$11.3K	Hold	3,575	–	–	﹤0.01%	2791
2023 Q2	$13.8K	Hold	3,575	–	–	﹤0.01%	2763
2023 Q1	$9.9K	Hold	3,575	–	–	﹤0.01%	2728
2022 Q4	$6.58K	Hold	3,575	–	–	﹤0.01%	2887
2022 Q3	$7K	Hold	3,575	–	–	﹤0.01%	2878
2022 Q2	$9K	Buy	+3,575	New	+$13.3K	﹤0.01%	2861

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Ameritas Investment Partners's NAUT Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 4,513 shares worth $8.44K. The stake represents ﹤0.01% of the portfolio and ranks #3040 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in NAUT as recently as Q1 2025.

Ameritas Investment Partners first reported a position in NAUT in Q2 2022 and has held it in 13 quarters since. The position peaked at $13.8K in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Ameritas Investment Partners held 4,513 shares of Nautilus Biotechnolgy worth $8.44K as of Q2 2026.
Nautilus Biotechnolgy was a new Ameritas Investment Partners position in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #3040 holding.
Ameritas Investment Partners first reported a position in Nautilus Biotechnolgy in Q2 2022 and has held it in 13 quarters since.
Ameritas Investment Partners's Nautilus Biotechnolgy position peaked at $13.8K in Q2 2023.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.